Analysis of 5,358 postmenopausal women from the Women’s Health Initiative Memory Study showed higher RC in individuals with Apolipoprotein E4 (apoE4) mutation, the most prevalent genetic risk factor of AD, was linked to increased dementia and cognitive impairment risk compared with lower RC group (34). This evidence concerns the gene APOE and Alzheimer disease.